ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 133 filers reported holding ANAPTYSBIO INC in Q3 2020. The put-call ratio across all filers is 62.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $461,015 | +77.2% | 25,669 | +114.7% | 0.00% | – |
| Q1 2023 | $260,184 | -13.0% | 11,957 | +23.9% | 0.00% | – |
| Q4 2022 | $298,961 | +39.7% | 9,647 | +14.8% | 0.00% | – |
| Q3 2022 | $214,000 | -72.0% | 8,403 | -77.7% | 0.00% | – |
| Q2 2022 | $765,000 | +116.1% | 37,680 | +269.4% | 0.00% | – |
| Q4 2021 | $354,000 | +1.1% | 10,200 | -37.4% | 0.00% | – |
| Q4 2020 | $350,000 | +23.2% | 16,288 | -15.4% | 0.00% | – |
| Q3 2020 | $284,000 | -52.3% | 19,246 | -47.6% | 0.00% | -100.0% |
| Q4 2019 | $596,000 | +129.2% | 36,709 | +394.7% | 0.00% | – |
| Q3 2019 | $260,000 | +26.8% | 7,421 | +104.2% | 0.00% | – |
| Q2 2019 | $205,000 | -76.6% | 3,635 | -58.7% | 0.00% | -100.0% |
| Q3 2018 | $877,000 | -4.7% | 8,791 | -0.6% | 0.00% | 0.0% |
| Q1 2018 | $920,000 | +140.8% | 8,842 | +133.2% | 0.00% | +100.0% |
| Q4 2017 | $382,000 | – | 3,792 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |